EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024

1
EpiCast Report Osteoarthritis - Epidemiology
Forecast to 2024
2
Report Description
EpiCast Report Osteoarthritis - Epidemiology
Forecast to 2024 Summary OA is a degenerative
disease of the entire joint, which involves the
cartilage, joint lining, ligaments, and
underlying bone. OA is the most common form of
joint disease. The most affected joints are the
knee, hip, hand, and spine. The diseases onset is
gradual and typically seen in middle-aged to
elderly people. OA is characterized by pain,
stiffness, swelling, crepitus, and limited
movement of the affected joint. OA will be the
fourth leading cause of disability by the year
2020. Epidemiologists forecast an increase in
the total prevalent cases of hand OA in the 7MM
from 150,635,612 total prevalent cases in 2014 to
175,213,683 total prevalent cases in 2024 at an
AGR of 1.63 during the forecast period.
Epidemiologists forecast that the total prevalent
cases of knee OA in the 7MM are expected to
increase from 110,840,501 total prevalent cases
in 2014 to 127,929,359 total prevalent cases in
2024 at an AGR of 1.54 during the forecast
period. Get Complete details _at_
http//www.bigmarketresearch.com/epicast-report-os
teoarthritis-epidemiology-forecast-to-2024-market
3
Report Description
Epidemiologists forecast that the total prevalent
cases of hip OA in the 7MM are expected to
increase from 61,150,916 total prevalent cases in
2014 to 69,699,696 total prevalent cases in 2024
at an AGR of 1.4 during the forecast period. The
diagnosed prevalent cases of hand OA in the 7MM
are expected to increase from 61,045,590
diagnosed prevalent cases in 2014 to 70,996,375
diagnosed prevalent cases in 2024 at an AGR of
1.63 during the forecast period. The diagnosed
prevalent cases of knee OA in the 7MM are
expected to increase from 37,845,305 diagnosed
prevalent cases in 2014 to 43,877,213 diagnosed
prevalent cases in 2024 at an AGR of 1.59 during
the forecast period. The diagnosed prevalent
cases of hip OA in the 7MM are expected to
increase from 15,116,094 diagnosed prevalent
cases in 2014 to 17,276,030 diagnosed prevalent
cases in 2024 at an AGR of 1.43 during the
forecast period. Enquire about this report
http//www.bigmarketresearch.com/report-enquiry/35
9517
4
Report Description
Scope - The Osteoarthritis (OA) EpiCast Report
provides an overview of the risk factors,
comorbidities, and the global and historical
trends for hand OA, knee OA, and hip OA in the
seven major markets (7MM) (US, France, Germany,
Italy, Spain, UK, and Japan). The report also
includes a 10-year epidemiological forecast for
the total prevalent cases and diagnosed prevalent
cases of hand OA, knee OA, and hip OA segmented
by age and sex in these markets. - The OA
epidemiology report is written and developed by
Masters- and PhD-level epidemiologists. -The
EpiCast Report is in-depth, high quality,
transparent and market-driven, providing expert
analysis of disease trends in the 7MM. Reasons
to buy The OA EpiCast series will allow you to -
- Develop business strategies by understanding
the trends shaping and driving the global OA
market. - Quantify patient populations in the
global OA market to improve product design,
pricing, and launch plans. - Organize sales and
marketing efforts by identifying the age groups
and sex that present the best opportunities for
OA therapeutics in each of the markets covered.
5
Table of Contents
Table Of Contents 1 Table of Contents 1 Table of
Contents 6 1.1 List of Tables 7 1.2 List of
Figures 9 2 Introduction 10 2.1 Catalyst 10 2.2
Related Reports 12 3 Epidemiology 13 3.1 Disease
Background 13 3.2 Risk Factors and Comorbidities
14 3.3 Global Trends 16 3.3.1 Total Prevalence of
OA - 7MM 16 3.3.2 Diagnosed Prevalence of OA -
7MM 16 3.4 Forecast Methodology 20 3.4.1 Sources
Used 27 3.4.2 Sources Not Used 32 3.4.3 Forecast
Assumptions and Methods 33
6
Table of Contents
3.5 Epidemiological Forecast for OA (2014-2024)
38 3.5.1 Total Prevalent Cases 38 3.5.2 Total
Prevalent Cases of Hip OA by Sex 51 3.5.3
Diagnosed Prevalent Cases 53 3.5.4 Severity of
Knee OA based on KL Grades 69 3.6 Discussion
70 3.6.1 Epidemiological Forecast Insight
70 3.6.2 Limitations of the Analysis 71 3.6.3
Strengths of the Analysis 72 4 Appendix 73 4.1
Bibliography 73 4.2 About the Authors 77 4.2.1
Epidemiologists 77 4.2.2 Reviewers 77 4.2.3
Global Director of Therapy Analysis and
Epidemiology 78 4.2.4 Global Head of Healthcare 79
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/epicast-report-os
teoarthritis-epidemiology-forecast-to-2024-market
Stay With Us
TELEPHONE [phone] EMAIL
help_at_bigmarketresearch.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States